Patients hospitalized with anti-glomerular basement membrane (anti-GBM) antibody disease, an autoimmune disease, are treated with a number of medications to stop the inflammation created by the disease. In this study, we want to see if adding the drug imlidifase to those usual treatments will stop the inflammation faster and helps reduce damage to the kidneys.
Thank you for your interest, but this study is not currently enrolling.
North Carolina (Statewide)
Vimal Derebail
Medicine-Nephrology
Clinical or Medical
Interventional
Kidneys and Liver
Lungs and Breathing
22-1821